Tiemonium are quaternary ammonium antimuscarinic agent with peripheral effect similar to those of atropine. Tiemonium strengthens calcium bonding with phospholipids and proteins thus stabilizing the cell membrane of the GI tract.
Xelcom 50 mg Tablet: Each film coated tablet contains 50 mg Tiemonium Methylsulphate INN.
Xelcom 5 mg/2 ml Injection: Each 2 ml ampoule contains 5 mg of Tiemonium
Xelcom 50 mg Tablet: Recommended oral dose of Tiemonium Methylsulphate tablet is 2-6 tablets (100-300 mg) daily in divided dosage as required. Xelcom 5 mg/2 ml Injection: Recommended injectable dose is one or two Tiemonium Methylsulphate Injection three times daily, through Intravenous route slowly or Intramuscular route.
Side effect with the use of Tiemonium Methylsulphate tablet is very rare.
Tiemonium Methylsulphate tablet should not be used in Glucoma or where acute pain of eyeball with vision disturbance was found. Also this drug should not be
used in patients with the disorder of prostate or urinary bladder.
Tiemonium Methylsulphate tablet may be used in pregnancy only if it is clearly needed by the assessment of risk benefit ratio.
Tiemonium Methylsulphate tablet may be used in lactating mother only if it is clearly needed by the assessment of risk benefit ratio. patients have not been established.
Tiemonium Methylsulphate tablet should not be used with other drugs without prior consult of a registered physician to avoid possible drug interaction.
There is not available data regarding the overdose of Tiemonium Methylsulphate.
Store in a cool & dry place at below 30°C, protect from light.
Keep the medicine out of the reach of children.
Xelcom 50 mg Tablet: Each box contains 5 x 10\'s tablets in blister pack.
Xelcom 5 mg/2 ml Injection: Each box contains 2 x 5\'s of 2ml ampoules in blister pack.